Table 2.
Frequency of abnormal variables among the groups divided by eGFR*
| eGFR, mL/min/1.73 m2 | ||||
|---|---|---|---|---|
| variables | 15--59 | 60--89 | ≥ 90 | p value |
| Body mass index, % | ||||
| ≥ 25 kg/m2 | 22.3 | 21.5 | 15.3 | 0.032 |
| HbA1c, % | ||||
| >5.8% | 13.1 | 9.1 | 9.3 | 0.336 |
| Serum choresterol level, % | ||||
| >5.69 mmol/L (>220 mg/dL) | 30 | 23.1 | 13.4 | < 0.001 |
| Serum triglyceride level, % | ||||
| >1.69 mmol/L (>150 mg/dL) | 21.5 | 16.5 | 10.7 | < 0.001 |
| Serum HDL choresterol level, % | ||||
| <1.03 mmol/L (<40 mg/dL) | 12.3 | 11.3 | 7.9 | 0.151 |
| AST, % | ||||
| >40 U/L | 3.8 | 4.9 | 4.1 | 0.737 |
| ALT, % | ||||
| >40 U/L | 3.8 | 7.9 | 7.1 | 0.235 |
| γ- GT, % | ||||
| >60 U/L | 12.3 | 14.4 | 16.7 | 0.404 |
| Blood pressure, % | ||||
| Systoric ≥ 140 and diastoric ≥ 90 mmHg | 48.5 | 37.3 | 25.4 | < 0.001 |
| U-ALB Ratio, % | ||||
| >17.9 mg/g | 29.5 | 18.3 | 13.9 | < 0.001 |
| U-Col4 Ratio, % | ||||
| >8.2 (male), >9.4 (female) μg/g | 20.2 | 16.6 | 18 | 0.541 |
* A χ2 test was used for statistical comparisons.
† Abbreviations are: HbA1c, glycated hemoglobin; HDL, high-density lipoprotein;
AST, aspartate amino transferase; ALT, alanine amino transferase; γ-GT, ganma-glutamyl transpeptidase; U-ALB Ratio, urinary albumin-creatinine ratio; U-Col4
Ratio, urinary type4 collagen creatinine ratio.